These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18005515)

  • 41. Resistance to antiretrovirals in HIV-infected pregnant women.
    Weinberg A; Forster-Harwood J; McFarland EJ; Pappas J; Davies JK; Kinzie K; Barr EA; Paul SM; Salbenblatt CR; Soda E; Vazquez A; Levin MJ
    J Clin Virol; 2009 May; 45(1):39-42. PubMed ID: 19329355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
    Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z
    Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sexuality, reproduction, and HIV in women: the impact of antiretroviral therapy in elective pregnancies in Cuba.
    Castro A; Khawja Y; González-Núñez I
    AIDS; 2007 Oct; 21 Suppl 5():S49-54. PubMed ID: 18090268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.
    Lima VD; Johnston K; Hogg RS; Levy AR; Harrigan PR; Anema A; Montaner JS
    J Infect Dis; 2008 Jul; 198(1):59-67. PubMed ID: 18498241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiretroviral medications and HIV.
    Kidd MR; Anderson J
    Aust Fam Physician; 2002 Feb; 31(2):135-9. PubMed ID: 11917823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
    Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adherence issues in children and adolescents receiving highly active antiretroviral therapy.
    Goode M; McMaugh A; Crisp J; Wales S; Ziegler JB
    AIDS Care; 2003 Jun; 15(3):403-8. PubMed ID: 12745395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cross-sectional study on rates and influential factors of standard medication for antiretroviral therapy in preventing mother-to-child transmission of HIV].
    Wang YZ; Li Y; Jiang CQ; Zheng M; Zhang Y; Xiong YH; Yang YY; Luo KM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Apr; 43(4):277-81. PubMed ID: 19534946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008.
    de Ruiter A; Mercey D; Anderson J; Chakraborty R; Clayden P; Foster G; Gilling-Smith C; Hawkins D; Low-Beer N; Lyall H; O'Shea S; Penn Z; Short J; Smith R; Sonecha S; Tookey P; Wood C; Taylor G
    HIV Med; 2008 Aug; 9(7):452-502. PubMed ID: 18840151
    [No Abstract]   [Full Text] [Related]  

  • 50. New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines.
    Read P; Costelloe S; Mullen J; O'Shea S; Lyons F; Hay P; Welch J; Larbalestier N; Taylor G; de Ruiter A
    HIV Med; 2008 Aug; 9(7):448-51. PubMed ID: 18840150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Knowledge of and adherence to antiretroviral therapy.
    Parienti JJ
    Clin Infect Dis; 2003 Sep; 37(6):861-2; author reply 862-3. PubMed ID: 12955656
    [No Abstract]   [Full Text] [Related]  

  • 52. Women and HIV.
    Laurence J
    AIDS Read; 2007 Dec; 17(12):574, 580. PubMed ID: 18178972
    [No Abstract]   [Full Text] [Related]  

  • 53. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women.
    Lazo M; Gange SJ; Wilson TE; Anastos K; Ostrow DG; Witt MD; Jacobson LP
    Clin Infect Dis; 2007 Nov; 45(10):1377-85. PubMed ID: 17968839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient self-report as a marker of adherence to antiretroviral therapy.
    Ho CF; Fong OW; Wong KH
    Clin Infect Dis; 2002 Jun; 34(11):1534-5. PubMed ID: 12015702
    [No Abstract]   [Full Text] [Related]  

  • 55. Factors related to medical appointment attendance after childbirth among HIV-infected women in the Paris region.
    Lemly D; Mandelbrot L; Meier F; Firtion G; Matheron S; Jeantils V; Scott TA
    AIDS Care; 2007 Mar; 19(3):346-54. PubMed ID: 17453568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. British HIV Association (BHIVA)/British Association for Sexual Health and HIV (BASHH) guidelines on provision of adherence support to individuals receiving antiretroviral therapy (2003).
    Poppa A; Davidson O; Deutsch J; Godfrey D; Fisher M; Head S; Horne R; Sherr L; ;
    HIV Med; 2004 Jul; 5 Suppl 2():46-60. PubMed ID: 15239716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A nurse- and pharmacist-led treatment advice clinic for patients attending an HIV outpatient clinic.
    Griffiths C; Miles K; Aldam D; Cornforth D; Minton J; Edwards S; Williams I
    J Adv Nurs; 2007 May; 58(4):320-6. PubMed ID: 17442036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bridging the gap between antiretroviral access and adherence in Mexico.
    Campero L; Herrera C; Kendall T; Caballero M
    Qual Health Res; 2007 May; 17(5):599-611. PubMed ID: 17478643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methylmalonic acidaemia in a 7-month-old following maternal highly active antiretroviral therapy during pregnancy.
    Silf K; McMaster P; Hendriksz C
    AIDS; 2007 Aug; 21(13):1835-6. PubMed ID: 17690593
    [No Abstract]   [Full Text] [Related]  

  • 60. The rules for successful HAART (highly active antiretroviral therapy).
    Newsline People AIDS Coalit N Y; 1998; ():30. PubMed ID: 11367500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.